Skip to main content
Erschienen in: European Journal of Pediatrics 2/2012

01.02.2012 | Original Paper

Feasibility study and control values of transient elastography in healthy children

verfasst von: Guido Engelmann, Caroline Gebhardt, Daniel Wenning, Elke Wühl, Georg F Hoffmann, Buket Selmi, Juergen Grulich-Henn, Jens Peter Schenk, Ulrike Teufel

Erschienen in: European Journal of Pediatrics | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Transient elastography (TE) is a new technique for the non-invasive assessment of liver fibrosis. The degree of fibrosis is equivalent to the liver stiffness measured in kilopascal (kPa). It is frequently used in adult patients with a mean normal stiffness of 4.4–5.5 kPa. Since 2008, liver stiffness can be measured even in small children and infants following the availability of a new probe with a smaller diameter (S-probe 5 mm) than the regular probe (M-probe 7 mm). We report control values for healthy children between 0 and 18 years and investigated the feasibility of this technique in a pediatric population. For control values, TE was performed in infants and children after exclusion of liver disease by medical history, clinical examination, blood investigation, and abdominal ultrasound. For feasibility analyses the results of all TE performed in our clinic were analyzed irrespective of the underlying disease. Liver stiffness was measured with the S-probe (thorax diameter <45 cm (S1) or 45–75 cm (S2)) and the M-probe (thorax diameter >75 cm) according to the manufacturer’s recommendations. A total of 240 healthy children were analyzed to establish control values. The median liver stiffness was 4.7 kPa resulting in an upper limit of normal of 6.47 kPa. Median values of stiffness were significantly age dependent with 4.40, 4.73, and 5.1 kPa in children 0–5, 6–11, and 12–18 years (p = 0.001) while the interquartile range decreased with age (0.8, 0.7, and 0.6 kPa). The resulting upper limit of normal (median plus 1.64 times standard deviation) was 5.96, 6.65, and 6.82 kPa. Girls between 11 and 18 years showed a significantly lower median stiffness than boys of the same age (4.7 vs. 5.6 kPa; p < 0.005). Feasibility was tested in 975 consecutive liver stiffness measurements (LSM) in children 0–18 years of age. Patients with invalid LSM were significantly younger than those with valid LSM (5.8 vs. 9.7 years, p < 0.0001), showed a significantly higher stiffness (10.2 vs. 6.17, p < 0.0001), and examinations took significantly longer (202 vs. 160 s, p < 0.0001). TE is technically possible in children of all age groups. The upper limit of normal increases significantly with age. Due to movement artifacts the measurement is reliable from the age of 6 without sedation. In younger children the number of invalid measurements increases significantly. Further studies are needed to asses the value of TE in the diagnosis and follow-up of liver disease in pediatric hepatology.
Literatur
1.
Zurück zum Zitat Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, Feldstein AE, Nobili V (2011) A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol 9:150–155PubMedCrossRef Alkhouri N, Carter-Kent C, Lopez R, Rosenberg WM, Pinzani M, Bedogni G, Feldstein AE, Nobili V (2011) A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol 9:150–155PubMedCrossRef
2.
Zurück zum Zitat Aube C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maiga MY, Penneau-Fontbonne D, Caron C, Cales P (1999) Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 30:472–478PubMedCrossRef Aube C, Oberti F, Korali N, Namour MA, Loisel D, Tanguy JY, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Rifflet H, Maiga MY, Penneau-Fontbonne D, Caron C, Cales P (1999) Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 30:472–478PubMedCrossRef
5.
Zurück zum Zitat Calvaruso V, Camma C, Di Marco V, Maimone S, Bronte F, Enea M, Dardanoni V, Manousou P, Pleguezuelo M, Xirouchakis E, Attanasio M, Dusheiko G, Burroughs AK, Craxi A (2010) Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy. J Viral Hepat 17:469–474PubMed Calvaruso V, Camma C, Di Marco V, Maimone S, Bronte F, Enea M, Dardanoni V, Manousou P, Pleguezuelo M, Xirouchakis E, Attanasio M, Dusheiko G, Burroughs AK, Craxi A (2010) Fibrosis staging in chronic hepatitis C: analysis of discordance between transient elastography and liver biopsy. J Viral Hepat 17:469–474PubMed
6.
Zurück zum Zitat Castera L, Negre I, Samii K, Buffet C (1999) Pain experienced during percutaneous liver biopsy. Hepatology 30:1529–1530PubMedCrossRef Castera L, Negre I, Samii K, Buffet C (1999) Pain experienced during percutaneous liver biopsy. Hepatology 30:1529–1530PubMedCrossRef
7.
Zurück zum Zitat Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350PubMedCrossRef Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V (2005) Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128:343–350PubMedCrossRef
8.
Zurück zum Zitat Castera L, Forns X, Alberti A (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48:835–847PubMedCrossRef Castera L, Forns X, Alberti A (2008) Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 48:835–847PubMedCrossRef
9.
Zurück zum Zitat Castera L, Foucher J, Bernard P, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Ledinghen V (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835PubMed Castera L, Foucher J, Bernard P, Carvalho F, Allaix D, Merrouche W, Couzigou P, de Ledinghen V (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835PubMed
10.
Zurück zum Zitat Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, Tan CK, Chow WC (2008) Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Pharmacol Ther 28:51–61PubMedCrossRef Chang PE, Lui HF, Chau YP, Lim KH, Yap WM, Tan CK, Chow WC (2008) Prospective evaluation of transient elastography for the diagnosis of hepatic fibrosis in Asians: comparison with liver biopsy and aspartate transaminase platelet ratio index. Aliment Pharmacol Ther 28:51–61PubMedCrossRef
11.
Zurück zum Zitat Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14:360–369PubMedCrossRef Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14:360–369PubMedCrossRef
12.
Zurück zum Zitat Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319PubMedCrossRef Cole TJ, Green PJ (1992) Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 11:1305–1319PubMedCrossRef
13.
Zurück zum Zitat Corpechot C, El Naggar A, Poupon R (2006) Gender and liver: is the liver stiffness weaker in weaker sex? Hepatology 44:513–514PubMedCrossRef Corpechot C, El Naggar A, Poupon R (2006) Gender and liver: is the liver stiffness weaker in weaker sex? Hepatology 44:513–514PubMedCrossRef
14.
Zurück zum Zitat de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Dhumeaux D, Beaugrand M (2006) Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 41:175–179PubMedCrossRef de Ledinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, Dhumeaux D, Beaugrand M (2006) Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 41:175–179PubMedCrossRef
15.
Zurück zum Zitat de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castera L, Sandrin L, Merrouche W, Lavrand F, Lamireau T (2007) Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 45:443–450PubMedCrossRef de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castera L, Sandrin L, Merrouche W, Lavrand F, Lamireau T (2007) Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 45:443–450PubMedCrossRef
16.
Zurück zum Zitat Dittrich M, Milde S, Dinkel E, Baumann W, Weitzel D (1983) Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 13:206–211PubMedCrossRef Dittrich M, Milde S, Dinkel E, Baumann W, Weitzel D (1983) Sonographic biometry of liver and spleen size in childhood. Pediatr Radiol 13:206–211PubMedCrossRef
17.
Zurück zum Zitat Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36:986–992PubMed Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 36:986–992PubMed
18.
Zurück zum Zitat Fung J, Lai C, Chan S, But D, Seto W, Cheng C, Wong DK, Lo C, Fan S, Yuen M (2010) Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am J Gastroenterol 105:1116–1122PubMedCrossRef Fung J, Lai C, Chan S, But D, Seto W, Cheng C, Wong DK, Lo C, Fan S, Yuen M (2010) Correlation of liver stiffness and histological features in healthy persons and in patients with occult hepatitis B, chronic active hepatitis B, or hepatitis B cirrhosis. Am J Gastroenterol 105:1116–1122PubMedCrossRef
19.
Zurück zum Zitat Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523–525PubMedCrossRef Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523–525PubMedCrossRef
20.
Zurück zum Zitat McHutchison J, Poynard T, Afdhal N (2006) Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group. Clin Gastroenterol Hepatol 4:1214–1220PubMedCrossRef McHutchison J, Poynard T, Afdhal N (2006) Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group. Clin Gastroenterol Hepatol 4:1214–1220PubMedCrossRef
21.
Zurück zum Zitat Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, Seitz HK, Mueller S (2008) Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48:1718–1723PubMedCrossRef Millonig G, Reimann FM, Friedrich S, Fonouni H, Mehrabi A, Buchler MW, Seitz HK, Mueller S (2008) Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48:1718–1723PubMedCrossRef
22.
Zurück zum Zitat Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, Stiefel P, Poschl G, Buchler MW, Seitz HK, Mueller S (2010) Liver stiffness is directly influenced by central venous pressure. J Hepatol 52:206–210PubMedCrossRef Millonig G, Friedrich S, Adolf S, Fonouni H, Golriz M, Mehrabi A, Stiefel P, Poschl G, Buchler MW, Seitz HK, Mueller S (2010) Liver stiffness is directly influenced by central venous pressure. J Hepatol 52:206–210PubMedCrossRef
23.
Zurück zum Zitat Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK (2010) Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 16:966–972PubMedCrossRef Mueller S, Millonig G, Sarovska L, Friedrich S, Reimann FM, Pritsch M, Eisele S, Stickel F, Longerich T, Schirmacher P, Seitz HK (2010) Increased liver stiffness in alcoholic liver disease: differentiating fibrosis from steatohepatitis. World J Gastroenterol 16:966–972PubMedCrossRef
24.
Zurück zum Zitat Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, Vizzutti F, Pinzani M, Rosenberg WM (2009) Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136:160–167PubMedCrossRef Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, Vizzutti F, Pinzani M, Rosenberg WM (2009) Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136:160–167PubMedCrossRef
25.
Zurück zum Zitat Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, Bedogni G, Pinzani M (2010) Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res 156:229–234PubMedCrossRef Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, Bedogni G, Pinzani M (2010) Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res 156:229–234PubMedCrossRef
26.
Zurück zum Zitat Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, Schiff ER (1996) The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 43:568–571PubMedCrossRef Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, Schiff ER (1996) The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 43:568–571PubMedCrossRef
27.
Zurück zum Zitat Quillin SP, Siegel MJ, Rothbaum R (1993) Hepatobiliary sonography in cystic fibrosis. Pediatr Radiol 23:533–535PubMedCrossRef Quillin SP, Siegel MJ, Rothbaum R (1993) Hepatobiliary sonography in cystic fibrosis. Pediatr Radiol 23:533–535PubMedCrossRef
28.
Zurück zum Zitat Roulot D, Czernichow S, Le Clesiau H, Costes J, Vergnaud A, Beaugrand M (2008) Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 48:606–613PubMedCrossRef Roulot D, Czernichow S, Le Clesiau H, Costes J, Vergnaud A, Beaugrand M (2008) Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 48:606–613PubMedCrossRef
29.
Zurück zum Zitat Sandrin L, Fourquet B, Hasquenoph J, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713PubMedCrossRef Sandrin L, Fourquet B, Hasquenoph J, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705–1713PubMedCrossRef
30.
Zurück zum Zitat Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A (2009) Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointestin Liver Dis 18:57–60PubMed Sirli R, Sporea I, Tudora A, Deleanu A, Popescu A (2009) Transient elastographic evaluation of subjects without known hepatic pathology: does age change the liver stiffness? J Gastrointestin Liver Dis 18:57–60PubMed
31.
32.
Zurück zum Zitat Tanner MS (2002) Mechanisms of liver injury relevant to pediatric hepatology. Crit Rev Clin Lab Sci 39:1–61PubMedCrossRef Tanner MS (2002) Mechanisms of liver injury relevant to pediatric hepatology. Crit Rev Clin Lab Sci 39:1–61PubMedCrossRef
33.
Zurück zum Zitat Wai C, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518–526PubMedCrossRef Wai C, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518–526PubMedCrossRef
34.
Zurück zum Zitat Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK, Chan HL (2011) Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 26:300–305PubMedCrossRef Wong GL, Wong VW, Chim AM, Yiu KK, Chu SH, Li MK, Chan HL (2011) Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J Gastroenterol Hepatol 26:300–305PubMedCrossRef
35.
Zurück zum Zitat Yasuda M, Shimizu I, Shiba M, Ito S (1999) Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29:719–727PubMedCrossRef Yasuda M, Shimizu I, Shiba M, Ito S (1999) Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29:719–727PubMedCrossRef
36.
Zurück zum Zitat Yeshua H, Oren R (2008) Non invasive assessment of liver fibrosis. Ann Transplant 13:5–11PubMed Yeshua H, Oren R (2008) Non invasive assessment of liver fibrosis. Ann Transplant 13:5–11PubMed
37.
Zurück zum Zitat Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet J, Beaugrand M (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54PubMedCrossRef Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet J, Beaugrand M (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41:48–54PubMedCrossRef
Metadaten
Titel
Feasibility study and control values of transient elastography in healthy children
verfasst von
Guido Engelmann
Caroline Gebhardt
Daniel Wenning
Elke Wühl
Georg F Hoffmann
Buket Selmi
Juergen Grulich-Henn
Jens Peter Schenk
Ulrike Teufel
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 2/2012
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-011-1558-7

Weitere Artikel der Ausgabe 2/2012

European Journal of Pediatrics 2/2012 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.